Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies.

Mwakingwe-Omari A, Lecrenier N, Naficy A, Curran D, Posiuniene I

Open source

DOI
10.1080/21645515.2023.2278362
Published
2023 Dec 15
Container
Human vaccines & immunotherapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21645515.2023.2278362,
  title = {Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies.},
  author = {Mwakingwe-Omari A and Lecrenier N and Naficy A and Curran D and Posiuniene I},
  year = {2023},
  journal = {Human vaccines \& immunotherapeutics},
  doi = {10.1080/21645515.2023.2278362},
  url = {https://doi.org/10.1080/21645515.2023.2278362}
}

RIS

TY  - JOUR
TI  - Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies.
AU  - Mwakingwe-Omari A
AU  - Lecrenier N
AU  - Naficy A
AU  - Curran D
AU  - Posiuniene I
PY  - 2023
JO  - Human vaccines & immunotherapeutics
DO  - 10.1080/21645515.2023.2278362
UR  - https://doi.org/10.1080/21645515.2023.2278362
ER  - 

APA

A, M., N, L., A, N., D, C., & I, P. (2023). Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies.. Human vaccines & immunotherapeutics. https://doi.org/10.1080/21645515.2023.2278362

Source records